| Title |
Decreasing rates of major lower-extremity amputation in people with diabetes but not in those without: a nationwide study in Belgium
|
|---|---|
| Published in |
Diabetologia, June 2018
|
| DOI | 10.1007/s00125-018-4655-6 |
| Pubmed ID | |
| Authors |
Heiner Claessen, Herve Avalosse, Joeri Guillaume, Maria Narres, Tatjana Kvitkina, Werner Arend, Stephan Morbach, Patrick Lauwers, Frank Nobels, Jacques Boly, Chris Van Hul, Kris Doggen, Isabelle Dumont, Patricia Felix, Kristien Van Acker, Andrea Icks |
| Abstract |
The reduction of major lower-extremity amputations (LEAs) is one of the main goals in diabetes care. Our aim was to estimate annual LEA rates in individuals with and without diabetes in Belgium, and corresponding time trends. Data for 2009-2013 were provided by the Belgian national health insurance funds, covering more than 99% of the Belgian population (about 11 million people). We estimated the age-sex standardised annual amputation rate (first per year) in the populations with and without diabetes for major and minor LEAs, and the corresponding relative risks. To test for time trends, Poisson regression models were fitted. A total of 5438 individuals (52.1% with diabetes) underwent a major LEA, 2884 people with above- and 3070 with below-the-knee major amputations. A significant decline in the major amputation rate was observed in people with diabetes (2009: 42.3; 2013: 29.9 per 100,000 person-years, 8% annual reduction, p < 0.001), which was particularly evident for major amputations above the knee. The annual major amputation rate remained stable in individuals without diabetes (2009: 6.1 per 100,000 person-years; 2013: 6.0 per 100,000 person-years, p = 0.324) and thus the relative risk reduced from 6.9 to 5.0 (p < 0.001). A significant but weaker decrease was observed for minor amputation in individuals with and without diabetes (5% and 3% annual reduction, respectively, p < 0.001). In this nationwide study, the risk of undergoing a major LEA in Belgium gradually declined for individuals with diabetes between 2009 and 2013. However, continued efforts should be made to further reduce the number of unnecessary amputations. |
X Demographics
The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 15 | 38% |
| Colombia | 2 | 5% |
| Guatemala | 1 | 3% |
| Mexico | 1 | 3% |
| Paraguay | 1 | 3% |
| Trinidad and Tobago | 1 | 3% |
| Germany | 1 | 3% |
| Unknown | 17 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 82% |
| Practitioners (doctors, other healthcare professionals) | 6 | 15% |
| Scientists | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 66 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 12 | 18% |
| Researcher | 9 | 14% |
| Student > Bachelor | 6 | 9% |
| Student > Ph. D. Student | 5 | 8% |
| Student > Postgraduate | 4 | 6% |
| Other | 9 | 14% |
| Unknown | 21 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 45% |
| Nursing and Health Professions | 5 | 8% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Economics, Econometrics and Finance | 1 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Other | 2 | 3% |
| Unknown | 25 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2022.
All research outputs
#1,158,928
of 24,488,567 outputs
Outputs from Diabetologia
#640
of 5,263 outputs
Outputs of similar age
#23,636
of 307,059 outputs
Outputs of similar age from Diabetologia
#19
of 60 outputs
Altmetric has tracked 24,488,567 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,263 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,059 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.